Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's dise
about
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's DiseasesThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingN-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line DataDopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.The Ca2+/Mn2+ ion-pump PMR1 links elevation of cytosolic Ca(2+) levels to α-synuclein toxicity in Parkinson's disease models.Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Dopamine and renal function and blood pressure regulation.Ornithine In Vivo Administration Disrupts Redox Homeostasis and Decreases Synaptic Na(+), K (+)-ATPase Activity in Cerebellum of Adolescent Rats: Implications for the Pathogenesis of Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome.Protective Role of Quercetin in Cadmium-Induced Cholinergic Dysfunctions in Rat Brain by Modulating Mitochondrial Integrity and MAP Kinase Signaling.Mechanisms underlying striatal vulnerability to 3-nitropropionic acid.Naringenin Mitigates Iron-Induced Anxiety-Like Behavioral Impairment, Mitochondrial Dysfunctions, Ectonucleotidases and Acetylcholinesterase Alteration Activities in Rat Hippocampus.Protective Effect of Curcumin by Modulating BDNF/DARPP32/CREB in Arsenic-Induced Alterations in Dopaminergic Signaling in Rat Corpus Striatum.
P2860
Q26859141-31C4B7DC-B474-4C91-99D0-E6C46A38DFE2Q26864995-A0BA8F84-A6D9-40E5-BE03-9EB3904BC48EQ30000089-CB8785EB-1561-4A81-A3CB-625121F636C4Q30429420-D32AFFC0-461D-45AE-AC36-7096F3C6086DQ36603128-F0CD3C37-4F0B-4D52-AE1C-CD3568B882EAQ38086474-77225362-7736-4DB5-A8B1-3881F7F6E621Q38111703-7BA74E44-8C9C-466E-9513-A83960E75B75Q41221054-266C4125-410B-408E-9DF5-6C42941E8F9DQ42695144-15AA327A-0E73-4024-B653-F5EA80555EA4Q43061451-FF737ACF-211C-4301-9D18-2286D51214C7Q46718540-02587595-1BD8-4792-8D4D-568014D26979Q50469925-A8404DCA-2E15-4764-A6B5-29767A698373
P2860
Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's dise
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Quinone and oxyradical scaveng ...... ve therapy of Parkinson's dise
@en
Quinone and oxyradical scaveng ...... ve therapy of Parkinson's dise
@nl
type
label
Quinone and oxyradical scaveng ...... ve therapy of Parkinson's dise
@en
Quinone and oxyradical scaveng ...... ve therapy of Parkinson's dise
@nl
prefLabel
Quinone and oxyradical scaveng ...... ve therapy of Parkinson's dise
@en
Quinone and oxyradical scaveng ...... ve therapy of Parkinson's dise
@nl
P2093
P2860
P1476
Quinone and oxyradical scaveng ...... therapy of Parkinson's disease
@en
P2093
Kalpita Banerjee
Maria B Bagh
Sasanka Chakrabarti
Sirsendu Jana
P2860
P304
P356
10.1080/10715760802158430
P577
2008-06-01T00:00:00Z